Amanote Research

Amanote Research

    RegisterSign In

Antiplatelet Drugs for Polycythaemia Vera and Essential Thrombocythaemia

Cochrane Database of Systematic Reviews
doi 10.1002/14651858.cd006503.pub3
Full Text
Open PDF
Abstract

Available in full text

Date

April 30, 2013

Authors
Alessandro SquizzatoErica RomualdiFrancesco PassamontiSaskia Middeldorp
Publisher

Wiley


Related search

Erythromelalgic Thrombotic Thrombocythemia (ETT) and Hemorrhagic Trombocythemia (HT) in Patients With Essential Thrombocythaemia (ET) and Polycythaemia Vera (PV)

Journal of Hematology & Thromboembolic Diseases
2014English

A Phase 2 Study of Simtuzumab in Patients With Primary, Post-Polycythaemia Vera or Post-Essential Thrombocythaemia Myelofibrosis

British Journal of Haematology
Hematology
2017English

Hyperuricaemia in Polycythaemia Vera

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1966English

Peripheral Gangrene in Polycythaemia Vera

Postgraduate Medical Journal
Medicine
1975English

Fortgeschrittene Post-Polycythaemia-Vera-Myelofibrose

Swiss Medical Forum ‒ Schweizerisches Medizin-Forum
2014English

Nonfamilial,MPLS505N-Mutated Essential Thrombocythaemia

Case Reports in Hematology
2013English

Megaloblastic Anaemia Alternating With Polycythaemia Vera

BMJ
1961English

Polycythaemia Rubra Vera and Congenital Deafness in Monozygotic Twins.

BMJ
1981English

Reno-Vascular Disease in Polycythaemia Rubra Vera.

Postgraduate Medical Journal
Medicine
1983English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy